Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TXA with rHuEPO and iron for perioperative anemia in elderly hip or distal femur fractures
ChiCTR2000038678Phase 4Not yet recruiting
- Sponsor
- Chongqing General Hospital
- Start
- Oct 2020
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tranexamic acid, epoetin alfa, Iron and Normal Saline-Benha University in hip fracture, Distal femur fracture (DFF) and anemia (4 arms), sponsored by Chongqing General Hospital. Primary endpoints: Hemoglobin, Hematocrit and 1 more. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
tranexamic acidepoetin alfaIronNormal Saline-Benha University
03
Conditions
hip fractureDistal femur fracture (DFF)anemia
Beyond the preview
Go deeper on ChiCTR2000038678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038678.